摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-amino-N-(furan-2-ylmethyl)-3-(6-methoxypyridin-3-yl)-1,2-oxazole-4-carboxamide

中文名称
——
中文别名
——
英文名称
5-amino-N-(furan-2-ylmethyl)-3-(6-methoxypyridin-3-yl)-1,2-oxazole-4-carboxamide
英文别名
——
5-amino-N-(furan-2-ylmethyl)-3-(6-methoxypyridin-3-yl)-1,2-oxazole-4-carboxamide化学式
CAS
——
化学式
C15H14N4O4
mdl
——
分子量
314.3
InChiKey
KEGUMCSCDHTKHT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    23
  • 可旋转键数:
    5
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    116
  • 氢给体数:
    2
  • 氢受体数:
    7

文献信息

  • Aminoisoxazole derivatives active as kinase inhibitors
    申请人:Cavicchioli Marcello
    公开号:US20050059657A1
    公开(公告)日:2005-03-17
    Compounds (I) which are aminoisoxazole derivatives or pharmaceutically acceptable salts thereof, together with pharmaceutical compositions comprising them are disclosed; these compounds or compositions are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders.
    本发明涉及氨基异噁唑衍生物(I)或其药学上可接受的盐,以及包含它们的药物组合物。这些化合物或组合物在治疗由蛋白激酶活性改变引起和/或相关的疾病方面具有用途,例如癌症、细胞增殖性疾病、阿尔茨海默病、病毒感染、自身免疫性疾病和神经退行性疾病。
  • AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS
    申请人:Pharmacia Italia S.p.A.
    公开号:EP1435948A1
    公开(公告)日:2004-07-14
  • [EN] AMINOISOXAZOLE DERIVATIVES ACTIVE AS KINASE INHIBITORS<br/>[FR] DÉRIVÉS D'AMINOISOXAZOLE AGISSANT COMME INHIBITEURS DE LA KINASE
    申请人:PHARMACIA ITALIA SPA
    公开号:WO2003013517A1
    公开(公告)日:2003-02-20
    Compounds (I) which are aminoisoxazole derivatives or pharmaceutically acceptable salts thereof, together with pharmaceutical compositions comprising them are disclosed; these compounds or compositions are useful in the treatment of diseases caused by and/or associated with an altered protein kinase activity such as cancer, cell proliferative disorders, Alzheimer's disease, viral infections, auto-immune diseases and neurodegenerative disorders.
查看更多